Section III - Non-Confidential Comment Context Biotherapeutic filters are process filters used during the manufacturing of bio-therapeutic drug products or samples such as therapeutic replacement of enzymes, antibodies, blood, derivatives of plasma, and biopharmaceuticals.

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/224342986 High-Efficiency PFC Abatement System Utilizing Plasma Decomposition and Ca(OH) /CaO Immobilization Article in IEEE Transactions on Semiconductor Manufacturing December 2008 DOI: 10.1109/TSM.2008.2005400 Source: IEEE Xplore CITATIONS 6 9 authors, including: Katsumasa Suzuki Taiyo Nippon Sanso Corporation 15 PUBLICATIONS 28 CITATIONS SEE PROFILE READS 1,167 Akinobu Teramoto Hiroshima University 512 PUBLICATIONS 3,161 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: Chemical Reaction Clarification View project Development of Laser Absorption Spectroscopy View project All content following this page was uploaded by Akinobu Teramoto on 31 May 2014.

p. 1 ~~zzE ~ 3~zZ Off-site Sampling PFOA Concentrations I T- Sample ID Decatur, AL verage PFOA (ppb) Location in Relation to 3M Decatur Facility S il Samples DAL-SB-603R-0-0000 DAL-SB-603R-0-0005 DAL-SB-603R-0-0010 DAL-SB-603R-0-0050 DAL-SB-603R-0-0100 DAL-SB-603R-DB-0100 NR 4 .03 5.06 3.71 1 .275 0.963 Southwest DAL-SB-604R-0-0000 DAL-SB-604R-0-0005 DAL-SB-604R-0-0010 DAL-SB-604R-0-0050 DAL-SB-604R-0-0100 DAL-~SB-605R-0-0000 DAL-SB-605R-DB-0000 DAL-SB-605R-0-0005 DAL-SB-605R-0-0010 DAL-SB-605R-0-0050 DAL-SB-605R-0-0100 DAL-SB-138R-0-0000 DAL-SB-138R-0-0005 DAL-SB-138R-0-0010 DAL-SB-138R-0-0050 DAL-SB-138R-0-0100 DAL-SB-138R-DB-0100 DAL-SB-602R-0-0000 DAL-SB-602R-0-0005 DAL-SB-602R-0-0010 DAL-SB-602R-0-0050 DAL-SB-602R-0-0100 DAL-SB-601 R-0-0000 DAL-SB-601 R-DB-0000 DAL-SB-601 R-0-0005 DAL-SB-601 R-0-0010 DAL-SB-601 R-DB-0010 DAL-SB-601 R-0-0050 DAL-SB-601 R-0-0100 DAL-SB-601 R-DB-0100 2~29 3.75 1 .54 5.615 0.356 7.905 7.795 7.64 2 .985 1 .02 0 .8555 28 .35 53 44 .05 104 311 .5 308 .5 6 .345 6.82 3.635 0.72 0.613 1 .93 2.095 1 .89 NR 1 .905 1 .1575 0.4575 0.442 Groundwater Samples South East Eastern boundary of facility West West DAL-GW-138L-0-060411 DAL-GW-138R-0-060412 DAL-GW-138S-0-060412 0.232 NR NR Eastern boundary of facility DAL-GW-605R-0-060412 0.0881 DAL GW 605L 0 060412 ~ ND I East I 'Average PFOA (ppb) = ng/mL for aqueous samples, nglg for solid samples .

~ ~~ Katherine E .

4W.

q6fe-ROBERT A.

"f\R. cZ fa U 03 To: Mary Dominiak/DC/USEPA/US@EPA, oppt.ncic@epamail.epa.gov cc: Subject: DuPont submission to AR-226 To : Mary F.

A R s.fi.6 _ \x q th Documents in TRP Database Source Title / D escription N o n -T R P Fluorinated Surfactants and Repellents (Kissa, 2001) Bioconcentration in Carp (study conducted for Japan METI) The First Environmental Survey of PFOS and Related Compounds in Japan Levels of PFOA and Other Related Compounds in the Blood of Japanese People 3M: Interactions of Fluorochemicals with Rat Liver Fatty Acid-Binding Protein 3M: Fluorochemicals in Human Blood (Dec. 2002) 3M: Branched vs.

3M Specialty Materials 3M Center St.

3M ENVIRONMENTAL LABORATORY REPORT NO.

3M ENVIRONMENTAL LABORATORY REPORT NO.

SOLUTIONS Weston Solutions, Inc. 1400 Weston Way P.O.

BACK TO MAIN 3M Environmental Laboratory Report No.

3M Specialty Materials 3M Center St.

NOTE TO FILE - AR 226 DATE: March 28, 2001 FROM: Karen Lannon SUBJECT: 3/26/01 Perfluoroalkanoic acids VC0^0 /o o ?